
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PIQ market cap is 80.5M. The company's latest EPS is AUD -0.0487 and P/E is -12.53.
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 3M | 2.97M | 3.43M | 3.17M | 3.27M |
Operating Income | -1.74M | -2.85M | -4.98M | -6.38M | -6.75M |
Net Income | -1.74M | -2.86M | -4.97M | -6.18M | -6.38M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 5.56M | 8.6M | 5.4M | 10.08M | 10.88M |
Total Liabilities | 1.12M | 991k | 2M | 1.75M | 1.63M |
Total Equity | 4.44M | 7.61M | 3.39M | 8.32M | 9.25M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -385k | -2.21M | -3.54M | -5.69M | -5.59M |
Investing | -1.59M | -191k | -129k | -1.17M | -388k |
Financing | 2.82M | 5.64M | 176k | 10.77M | 6.59M |
Market Cap | 80.5M |
Price to Earnings Ratio | -12.53 |
Price to Sales Ratio | 24.4 |
Price to Cash Ratio | 12.03 |
Price to Book Ratio | 8.63 |
Dividend Yield | - |
Shares Outstanding | 130.89M |
Average Volume (1 week) | 106.5k |
Average Volume (1 Month) | 139.17k |
52 Week Change | -39.71% |
52 Week High | 1.40 |
52 Week Low | 0.55 |
Spread (Intraday) | 0.02 (3.15%) |
Company Name | Proteomics International Laboratories Ltd |
Address |
suite 13 perth, western australia 6005 |
Website | https://www.proteomicsinternational.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions